185 related articles for article (PubMed ID: 32695103)
1. Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer.
Comi M; Amodio G; Passeri L; Fortunato M; Santoni de Sio FR; Andolfi G; Kajaste-Rudnitski A; Russo F; Cesana L; Gregori S
Front Immunol; 2020; 11():1260. PubMed ID: 32695103
[TBL] [Abstract][Full Text] [Related]
2. IL-10-Engineered Dendritic Cells Modulate Allogeneic CD8
Fortunato M; Amodio G; Gregori S
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298076
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 Gene-Modified Dendritic Cell-Induced Type 1 Regulatory T Cells Induce Transplant-Tolerance and Impede Graft Versus Host Disease After Allogeneic Stem Cell Transplantation.
Wan J; Huang F; Hao S; Hu W; Liu C; Zhang W; Deng X; Chen L; Ma L; Tao R
Cell Physiol Biochem; 2017; 43(1):353-366. PubMed ID: 28869950
[TBL] [Abstract][Full Text] [Related]
4. Murine Flt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties.
Miller G; Pillarisetty VG; Shah AB; Lahrs S; DeMatteo RP
J Immunol; 2003 Apr; 170(7):3554-64. PubMed ID: 12646617
[TBL] [Abstract][Full Text] [Related]
5. Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseases.
Passeri L; Andolfi G; Bassi V; Russo F; Giacomini G; Laudisa C; Marrocco I; Cesana L; Di Stefano M; Fanti L; Sgaramella P; Vitale S; Ziparo C; Auricchio R; Barera G; Di Nardo G; Troncone R; Gianfrani C; Annoni A; Passerini L; Gregori S
J Autoimmun; 2023 Jul; 138():103051. PubMed ID: 37224733
[TBL] [Abstract][Full Text] [Related]
6. Making dendritic cells from the inside out: lentiviral vector-mediated gene delivery of granulocyte-macrophage colony-stimulating factor and interleukin 4 into CD14+ monocytes generates dendritic cells in vitro.
Koya RC; Weber JS; Kasahara N; Lau R; Villacres MC; Levine AM; Stripecke R
Hum Gene Ther; 2004 Aug; 15(8):733-48. PubMed ID: 15319031
[TBL] [Abstract][Full Text] [Related]
7. Lentivirally transduced dendritic cells as a tool for cancer immunotherapy.
Breckpot K; Dullaers M; Bonehill A; van Meirvenne S; Heirman C; de Greef C; van der Bruggen P; Thielemans K
J Gene Med; 2003 Aug; 5(8):654-67. PubMed ID: 12898635
[TBL] [Abstract][Full Text] [Related]
8. Transduction of dendritic cell progenitors with a retroviral vector encoding viral interleukin-10 and enhanced green fluorescent protein allows purification of potentially tolerogenic antigen-presenting cells.
Takayama T; Tahara H; Thomson AW
Transplantation; 1999 Dec; 68(12):1903-9. PubMed ID: 10628772
[TBL] [Abstract][Full Text] [Related]
9. Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells.
Andolfi G; Fousteri G; Rossetti M; Magnani CF; Jofra T; Locafaro G; Bondanza A; Gregori S; Roncarolo MG
Mol Ther; 2012 Sep; 20(9):1778-90. PubMed ID: 22692497
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10-Producing DC-10 Is a Unique Tool to Promote Tolerance
Comi M; Amodio G; Gregori S
Front Immunol; 2018; 9():682. PubMed ID: 29686676
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of lentivirus-mediated interleukin -12 gene modified dendritic cells in human lung cancer in vitro.
Ahmed Ali HA; Di J; Mei W; Zhang YC; Li Y; Du ZW; Zhang GZ
Asian Pac J Cancer Prev; 2014; 15(2):611-6. PubMed ID: 24568466
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone turns tumor antigen-presenting cells into tolerogenic dendritic cells with T cell inhibitory functions.
Falcón-Beas C; Tittarelli A; Mora-Bau G; Tempio F; Pérez C; Hevia D; Behrens C; Flores I; Falcón-Beas F; Garrido P; Ascui G; Pereda C; González FE; Salazar-Onfray F; López MN
Immunobiology; 2019 Sep; 224(5):697-705. PubMed ID: 31221438
[TBL] [Abstract][Full Text] [Related]
13. Enhanced efficiency by centrifugal manipulation of adenovirus-mediated interleukin 12 gene transduction into human monocyte-derived dendritic cells.
Nishimura N; Nishioka Y; Shinohara T; Sone S
Hum Gene Ther; 2001 Mar; 12(4):333-46. PubMed ID: 11242526
[TBL] [Abstract][Full Text] [Related]
14. CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection.
Gao JX; Madrenas J; Zeng W; Cameron MJ; Zhang Z; Wang JJ; Zhong R; Grant D
Immunology; 1999 Oct; 98(2):159-70. PubMed ID: 10540214
[TBL] [Abstract][Full Text] [Related]
15. Potent maturation of monocyte-derived dendritic cells after CD40L lentiviral gene delivery.
Koya RC; Kasahara N; Favaro PM; Lau R; Ta HQ; Weber JS; Stripecke R
J Immunother; 2003; 26(5):451-60. PubMed ID: 12973034
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of transduced primary human dendritic cells generated by the use of three different lentiviral vector systems.
Grabski E; Waibler Z; Schüle S; Kloke BP; Sender LY; Panitz S; Cichutek K; Schweizer M; Kalinke U
Mol Biotechnol; 2011 Mar; 47(3):262-9. PubMed ID: 20938757
[TBL] [Abstract][Full Text] [Related]
17. Effective induction of immune tolerance by portal venous infusion with IL-10 gene-modified immature dendritic cells leading to prolongation of allograft survival.
Zhang M; Wang Q; Liu Y; Sun Y; Ding G; Fu Z; Min Z; Zhu Y; Cao X
J Mol Med (Berl); 2004 Apr; 82(4):240-9. PubMed ID: 15168681
[TBL] [Abstract][Full Text] [Related]
18. Alteration of T cell immunity by lentiviral transduction of human monocyte-derived dendritic cells.
Chen X; He J; Chang LJ
Retrovirology; 2004 Nov; 1():37. PubMed ID: 15518595
[TBL] [Abstract][Full Text] [Related]
19. Monocytes transduced with lentiviral vectors expressing hepatitis C virus non-structural proteins and differentiated into dendritic cells stimulate multi-antigenic CD8(+) T cell responses.
Jirmo AC; Koya RC; Sundarasetty BS; Pincha M; Yu GY; Lai M; Bakshi R; Schlaphoff V; Grabowski J; Behrens G; Wedemeyer H; Stripecke R
Vaccine; 2010 Jan; 28(4):922-33. PubMed ID: 19931383
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells lentivirally engineered to overexpress interleukin-10 inhibit contact hypersensitivity responses, despite their partial activation induced by transduction-associated physical stress.
Besche V; Wiechmann N; Castor T; Trojandt S; Höhn Y; Kunkel H; Grez M; Grabbe S; Reske-Kunz AB; Bros M
J Gene Med; 2010 Mar; 12(3):231-43. PubMed ID: 20140891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
